Epilepsy is one of the most common neurological disorders affecting about 60 lakh people in India. In 70 % of these patients, seizures can be controlled with medical treatment. However, 30 % of patients, (approximately 16 lakh patients in India), have drug-resistant epilepsy which is
~The New Lab in Sambalpur is SRL’s 2nd lab in Odisha~ SRL Diagnostics, India’s largest diagnostics service provider today announced the launch of a new laboratory in Sambalpur, Odisha. The state of the art laboratory has the capacity to conduct 20,000+ tests in a month ranging
----------------------------------------------------------------------------------------- The Indo-French Healthcare Symposium 2022: together for tomorrow's health" is taking place on 28th November 2022, in New Delhi at the Leela palace. This healthcare event is organised by Business France, in collaboration with the Indo-French Chamber of Commerce and Industry, the French Institute in
There is an urgent need to invest in healthcare systems to build resilience against future crises and the growing burden of disease, according to new research presented at a Global Summit today (22 November 2022). The research, commissioned by the Partnership for Health System Sustainability and
The solar plant will generate 45 lakh units (3.265MWp) of clean electricity annually, offsetting 3300 tons of carbon emissions The 2.25MW solar installation is expected to reduce up to 70% of energy expenditure at two hospitals in Karnataka In an effort to conserve
Collaboration to strengthen healthcare system, reduce prevalence and improve health outcomes for patients diagnosed with Cardiovascular and COPD/Asthma disease in Alwar Lupin Human Welfare and Research Foundation (LHWRF), the Corporate Social Responsibility (CSR) arm of Lupin Limited (‘Lupin’ BSE: 500257 |NSE: LUPIN | Reuters: LUPIN.BO |Bloomberg:
~ Program will fight the rising incidence of antimicrobial (drug) resistance and improve patient outcomes ~ Apollo, Asia's foremost integrated healthcare services provider today announced the launch of an Antimicrobial Stewardship Programme (Apollo ASP) at a national level. The program will sensitize care providers on Antimicrobial
Gains access to global capital and market through the acquisition of controlling interest in Avra Medical Robotics, a NASDAQ-listed company in the USA An Indian Medtech Start-up Company is ready to conquer the global market. India’s SS Innovation has now gained access to global capital &
In continuation of its endeavour to ensure world-class cancer care services and commitment towards cancer free society, HCG NCHRI Cancer centre Nagpur launched a unique campaign towards Transgender and other LGBT community by organising a one-day free cancer screening camp at the hospital campus, where
Revenue for Q2 FY22 of INR 4,200 Million, a growth of 19.3% (y-o-y) and 2.9% (q-o-q) Revenue for H1 FY23 of INR 8281 Million, a growth of 22.7% (y-o-y) EBITDA for Q2 FY23 of INR 810 Million, a growth of 28.0% (y-o-y) and 7.2% (q-o-q) EBITDA for
